The Phosphodiesterase Inhibitor IBMX Suppresses TNF-α Expression in Human Adipocyte Precursor Cells: A Possible Explanation for its Adipogenic Effect
- 1 June 1999
- journal article
- research article
- Published by Georg Thieme Verlag KG in Hormone and Metabolic Research
- Vol. 31 (06) , 359-362
- https://doi.org/10.1055/s-2007-978754
Abstract
Tumor necrosis factor-α (TNF) is known to inhibit fat cell development in vitro and to be expressed in adipose tissue suggesting that it may act as an auto-/paracrine regulator of adipose tissue mass in vivo. We demonstrate here that endogenous TNF-mRNA expression of cultured human preadipocytes and adipocytes is suppressed by the unspecific phosphodiesterase inhibitor 3-isobutyl-1-methylxanthine (IBMX), which is frequently used to trigger the differentiation process. As assessed by the measurement of glycerophosphate dehydrogenase, IBMX stimulated the differentiation of human preadipocytes in a dose dependent manner up to threefold but remained ineffective when cells were simultaneously treated with 1 nM TNF. These results suggest that the adipogenic effect of IBMX is mediated by suppression of endogenous TNF production.Keywords
This publication has 0 references indexed in Scilit: